Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (72)

2024

  1. A global action agenda for turning the tide on fatty liver disease

    Hepatology, Vol. 79, Núm. 2, pp. 502-523

  2. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  3. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

  4. Limitation of life support treatments in Spanish Intensive Care Units: Analysis of the ETHICUS II study

    Medicina Intensiva, Vol. 48, Núm. 5, pp. 247-253

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

2022

  1. Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study

    Medicina Intensiva, Vol. 46, Núm. 4, pp. 179-191

2021

  1. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1928-1936

  2. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity

    Theranostics, Vol. 11, Núm. 14, pp. 6983-7004

2020

  1. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic

    European Journal of Clinical Investigation, Vol. 50, Núm. 12

  2. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 71, Núm. 9, pp. 2354-2362

  3. Randomized study to evaluate the impact of telemedicine care in patients with type 1 diabetes with multiple doses of insulin and suboptimal HbA1c in Andalusia (Spain): PLATEDIAN study

    Diabetes Care, Vol. 43, Núm. 2, pp. 337-342

  4. Towards the elimination of hepatitis C: Implementation of reflex testing in Andalusia

    Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 7, pp. 515-519

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  2. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy

    Annals of Hematology, Vol. 98, Núm. 8, pp. 1953-1959

  3. Multidisciplinary palliative care at the end of life of critically ill patient

    Medicina Intensiva, Vol. 43, Núm. 2, pp. 61-62

  4. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

    Journal of Hepatology, Vol. 71, Núm. 1, pp. 45-51

  5. THE IMPORTANCE OF AN INTERPROFESSIONAL PALLIATIVE APPROACH FOR THE CRITICAL PATIENT

    Enfermeria Intensiva, Vol. 30, Núm. 1, pp. 1-3

  6. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion

    PLoS ONE, Vol. 14, Núm. 9

2018

  1. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481

  2. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society

    Journal of Clinical Lipidology, Vol. 12, Núm. 6, pp. 1482-1492.e3